Helixate Nexgen

In the US, Helixate NexGen is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

UK matches:

• Helixate NexGen 1000 IU
• Helixate NexGen 2000 IU
• Helixate NexGen 250 IU
• Helixate NexGen 500 IU
• Helixate NexGen (SPC)

Ingredient matches for Helixate NexGen

Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Helixate NexGen in the following countries:

• France


• Norway


• Spain


• Sweden


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.